MedCity Influencers

From Scarcity to Possibility: What Perfusion Technologies Mean for the Organ Transplantation Industry

Machine perfusion extends the viability of organs outside the body by circulating oxygen and nutrients through a specialized solution. This means organs can travel greater distances, medical teams have more time to make thoughtful decisions and patients have a better chance of getting a match. 

Hand arranging wood block stacking with icon internal organs

Every transplant begins as a race against time. Once an organ leaves the body, its condition begins to decline. For decades, static cold storage, where an organ is placed on ice, has been the standard way to slow this process. Static cold storage can delay damage and buy time, but it cannot stop it, and it is not long enough. 

Time limitation defines every step of transplantation. Surgeons, coordinators and donor hospitals all work against a clock that never stops ticking. In that environment, decisions must come quickly, travel distances remain short and there is little room for hesitation or delay.

Today, a new frontier in organ preservation is taking place — machine perfusion technology. Machine perfusion extends the viability of organs outside the body by circulating oxygen and nutrients through a specialized solution. This means organs can travel greater distances, medical teams have more time to make thoughtful decisions and patients have a better chance of getting a match. 

presented by

From passive storage to active preservation

Static cold storage has served its purpose for many years, but it is a passive process. It slows the activity of an organ without preserving true vitality. Without oxygen and nutrients, cells weaken.

Machine perfusion changes this approach entirely. It provides a controlled environment with a steady flow of oxygen and nutrients to keep the organ stable and functional. One method, hypothermic oxygenated perfusion (HOPE), uses cold temperatures and represents a fundamental step forward in organ care

Medical professionals are embracing new scientific insights about organ transplantation. It is no longer only about acquiring an organ. It is about preserving its health, keeping its function and ensuring that each donated organ has a chance to save a life.

Addressing the main barriers in organ transplantation

Machine perfusion solves three persistent challenges in organ transplantation: limited time, geographic barriers and underutilized donor organs.

  • Time has always been the most unforgiving factor. Extra hours in organ transplantation are a gift. It transforms what was once a frantic rush into a more deliberate process. Perfusion technologies give clinicians valuable time to make careful, informed decisions, helping maintain organ health and extend viability. It also provides additional time to evaluate and prepare the organ for both the patient and the donor family.
  • Historically, geography plays a significant role in who is able to receive a transplant. Organs on static cold storage only have a fraction of the time available outside of the body compared to machine perfusion. Meaning, they can only travel a fraction of the distance. This greatly diminishes the number of recipients eligible to receive an organ and reduces inequities in the system. By extending preservation time, perfusion technologies help the system follow its own rules, prioritizing patients based on urgency rather than proximity.
  • The third barrier is combating underutilized donated organs. Far too many organs go unused in the United States each year. For abdominal organs such as livers and kidneys, between 35-40% go unused. This number skyrockets when it comes to donated hearts and lungs, where around 75-80% are never transplanted. Machine perfusion creates a more stable environment for preservation, which allows organs once deemed unsuitable – those from older donors or those with certain health conditions – to be viable. This enables surgeons to confidently utilize organs that might otherwise be discarded, and helps match organs to patients more effectively, thereby reducing the number of wasted organs. 

The ethical dimension

For too long, the urgency of time has forced difficult compromises. A system that incorporates perfusion can correct these imbalances. Longer preservation windows allow organs to be distributed more fairly. Donor families can have greater confidence that their loved one’s contribution will help someone in need. Clinicians gain the clarity and time to operate with confidence.

At its core, perfusion technologies are not only a scientific advancement but an ethical one. It supports fairness, transparency and accountability in how life-saving resources are managed and used.

Toward a more ethical, effective future

Perfusion is not a concept for the future. It is happening now and changing what is possible in one of medicine’s most demanding fields. Extending organ viability means extending opportunity. A system built on perfusion is more ethical, more transparent and has more people off the waitlist. 

Adoption must expand and training and integration needs to grow alongside clinical experience. The goal is clear: nobody should die waiting for a new organ. 

The journey from scarcity to possibility is already underway. Perfusion technologies provide the tools to honor every donated organ, help every patient and make every decision with greater confidence and care. Time will always matter in transplantation, but with innovation and collaboration, it can finally help save more lives.

Photo: eternalcreative, Getty Images

Christoffer Rosenblad is the CEO at XVIVO. As CEO, Christoffer leads the company toward its vision that nobody should die waiting for a new organ and helps clinicians and researchers push the boundaries of organ transplantation, making it more accessible and reliable for people around the world. Over the past decade, Christoffer has served as COO, CFO, and Head of XVIVO North America, playing key roles in shaping its strategy, driving global growth, and nurturing a culture of innovation rooted in collaboration and integrity.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.